Organization · Venture Capital

Norwich Ventures

Norwich Ventures is a specialized venture capital firm based in Waltham, Massachusetts, focusing on early-stage investments in the medtech sector. The firm targets technologies that address significant unmet medical needs.

Venture CapitalFunder

Overview

What Norwich Ventures does

What Norwich Ventures is

Norwich Ventures is a specialized venture capital firm based in Waltham, Massachusetts, focusing on early-stage investments in the medtech sector. The firm targets technologies that address significant unmet medical needs.

How it participates in the startup ecosystem

The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.

Operational profile

Organization status and context

Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.

Operational status
Active
Organization type
Venture Capital
Founded
Founded in 2004
Approximate age
About 22 years
Structured capabilities
Funder
Last reviewed
April 10, 2026

Official channels

Find Norwich Ventures elsewhere

Open the official website or a supported primary organization account.

Capability profile

Norwich Ventures as a funder

Investment thesis

Best-in-class medtech with capital-efficient approach, clear barriers to entry, and quick path to proof of concept. Focus on large unmet medical needs.

Focus narrative

Norwich Ventures invests in early-stage medtech companies across various fields of medicine, including electrophysiology, genomics, and women's health. The firm provides initial capital in seed and early-stage rounds and emphasizes a long-term investment perspective.

Value beyond capital

Norwich Ventures provides not only capital but also strategic guidance and industry connections to help portfolio companies navigate the complexities of the medtech landscape.

Focus and fit

Stages
Seed
Sectors
Healthcare

Availability

Currently deploying
Yes

Portfolio and track record

Recorded notable exits
Intelligent Bio-systems and Rhythmia Medical

Portfolio context

Notable past investments include companies that have been acquired by major firms such as Medtronic, Tempus, Qiagen, Laborie, Terumo, and Boston Scientific. Current portfolio companies include Affera (cardiac mapping/ablation), Arterys (medical imaging AI), IonPath (spatial biology/proteomics), Lexington Medical (surgical stapling), Podimetrics (diabetic foot monitoring), Vaxess (vaccine delivery), and Intelligent Bio-systems (DNA sequencing, acquired by Qiagen).

Connected ecosystem

Continue from Norwich Ventures

These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.

Common questions

What to know about Norwich Ventures

Upseed classifies Norwich Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.

Next step

Keep comparing startup organizations

Return to the organization index or continue through a verified sector, place, peer, or program connected to this profile.

Source and update disclosure

Know what this page is based on

Source basis

Public organization and program material, official websites, and structured Upseed records.

Last reviewed

April 10, 2026

Known limits

Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.

Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.